Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001558370-25-009619
Filing Date
2025-07-25
Accepted
2025-07-25 17:04:52
Documents
10

Document Format Files

Seq Description Document Type Size
1 S-3 cydy-20250725xs3.htm S-3 255947
2 EX-5.1 cydy-20250725xex5d1.htm EX-5.1 30186
3 EX-23.1 cydy-20250725xex23d1.htm EX-23.1 3406
4 EX-23.2 cydy-20250725xex23d2.htm EX-23.2 3654
5 EX-FILING FEES cydy-20250725xexfees.htm EX-FILING FEES 40032
6 GRAPHIC cydy-20250725xex5d1002.jpg GRAPHIC 9240
7 GRAPHIC cydy-20250725xex5d1003.jpg GRAPHIC 4585
8 GRAPHIC cydy-20250725xex5d1004.jpg GRAPHIC 10877
9 GRAPHIC cydy-20250725xex5d1005.jpg GRAPHIC 4645
10 GRAPHIC cydy-20250725xs3008.jpg GRAPHIC 14591
  Complete submission text file 0001558370-25-009619.txt   395708
Mailing Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660
Business Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660 360-980-8524
CytoDyn Inc. (Filer) CIK: 0001175680 (see all company filings)

EIN.: 753056237 | State of Incorp.: DE | Fiscal Year End: 0531
Type: S-3 | Act: 33 | File No.: 333-288970 | Film No.: 251152318
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)